Compass Therapeutics, Inc. Profile Avatar - Palmy Investing

Compass Therapeutics, Inc.

Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-…

Biotechnology
US, Boston [HQ]
Strategy & Leadership

Officers & BofD Beta

  • Form 3/4/5
  • Proxy DEF-14A

Total Compensation

- No data, only available if we have DEF 14A compensations in place -
Officers
Name & Position Research Last Appearance
- No data available -
Board of Directors (BofD)
Name & Position Research Last Appearance
- No data available -
End of CMPX's Analysis
CIK: 1738021 CUSIP: 20454B104 ISIN: US20454B1044 LEI: - UEI: -
Secondary Listings
CMPX has no secondary listings inside our databases.